Partial Impairment of Cytokine Responses in Tyk2-Deficient Mice-Reference-Cited by-同舟云学术

Partial Impairment of Cytokine Responses in Tyk2-Deficient Mice

Published:2000-10 Issue:4 Volume:13 Page:549-560
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Karaghiosoff Marina,Neubauer Hans,Lassnig Caroline,Kovarik Pavel,Schindler Heike,Pircher Hanspeter,McCoy Barbara,Bogdan Christian,Decker Thomas,Brem Gottfried,Pfeffer Klaus,Müller Mathias

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference64 articles.

1. Requirement for distinct Janus kinases and STAT proteins in T cell proliferation versus IFN-gamma production following IL-12 stimulation;Ahn;J. Immunol.,1998

2. Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2;Bacon;J. Exp. Med.,1995

3. Inducible nitric-oxide synthase plays a minimal role in lymphocytic choriomeningitis virus-induced, T cell-mediated protective immunity and immunopathology;Bartholdy;J. Gen. Virol.,1999

4. Antiviral protection by CD8+ versus CD4+ T cells. CD8+ T cells correlating with cytotoxic activity in vitro are more efficient in anti-vaccinia virus protection than CD4-dependent IL;Binder;J. Immunol.,1991

5. Mechanism of suppression of macrophage nitric oxide release by IL13;Bogdan;J. Immunol.,1997

Cited by 361 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in Japanese patients with moderate to severe plaque, erythrodermic, or generalized pustular psoriasis: Efficacy and safety results from an open‐label, phase 3 trial;The Journal of Dermatology;2024-01-24

2. Paradoxical psoriasis: The flip side of idiopathic psoriasis or an autocephalous reversible drug reaction?;Journal of Translational Autoimmunity;2023-12

3. Genetic examination of hematological parameters in SARS-CoV-2 infection and COVID-19;Blood Cells, Molecules, and Diseases;2023-11

4. A novel highly selective allosteric inhibitor of tyrosine kinase 2 (TYK2) can block inflammation- and autoimmune-related pathways;Cell Communication and Signaling;2023-10-16

5. Specificity and promiscuity of JAK recruitment regulates pleiotropy of cytokine-receptor signaling;2023-10-04